Multidisciplinary Approaches in Translational Medicine

Abstract

Translational medicine -- the systematic process of converting biomedical discoveries into clinical applications that improve patient outcomes -- has historically been characterised as a unidirectional pipeline from bench to bedside. Contemporary practice recognises instead a bidirectional cycle in which clinical observations and patient data continuously inform basic research priorities, and in which multidisciplinary team composition, organisational structure, and data infrastructure determine how efficiently discoveries traverse the translational pathway. Despite substantial investment in translational research centres across Europe, systematic comparison of which multidisciplinary team models and infrastructure configurations most reliably produce clinical implementation remains lacking. We evaluated five multidisciplinary translational medicine frameworks across 124 research programmes at 28 European academic medical centres in Zurich, Berlin, Rotterdam, Milan, and Warsaw between 2012 and 2023, covering oncology, cardiovascular disease, metabolic disorders, and rare diseases. Frameworks ranged from discipline-siloed research with sequential handoffs through fully integrated co-located multidisciplinary teams with embedded clinical data science and real-time patient cohort access. Performance was assessed by our Translational Medicine Effectiveness Score (TMES), integrating time-to-first-in-human, clinical impact within 10 years, team productivity, equity in disease area prioritisation, and regulatory milestone achievement rate. The integrated co-located framework achieved the highest TMES (0.912), reducing median time-to-first-in-human from 8.4 years (siloed) to 4.2 years and achieving clinical implementation in 68.4% of programmes versus 22.6% for discipline-siloed approaches. Embedded clinical data science capability was the single organisational feature most strongly associated with translational success across all frameworks.